A phase 3, open-label, extension study of S-6810 in patients with mycosis fungoides or Sezary syndrome
Phase 3
- Conditions
- Mycosis fungoides or Sezary syndrome
- Registration Number
- JPRN-jRCT2080222030
- Lead Sponsor
- SHIONOGI & CO., LTD.
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Sex
- All
- Target Recruitment
- Not specified
Inclusion Criteria
Main inclusion criteria
1. Patients who completed the phase 2 open-label study.
Exclusion Criteria
Main exclusion criteria
1. Patients whose therapy evaluation in the phase 2 open-label study was progressive disease, or patients who got worse in obvious at end of administration.
2. Patients who withdrew from the phase 2 open-label study.
Study & Design
- Study Type
- Interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method Safety
- Secondary Outcome Measures
Name Time Method Efficacy (response rate)